tirzepatide surmount-1 weight loss percent 72 weeks results Effect of once-weekly on body in comparison with Lilly released results for SURMOUNT-2,

Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index

[15] [19] Wegovy promotes weight loss partly by reducing appetite and food intake, which could theoretically exacerbate nutritional deficiencies if dietary quality is not maintained

They must attest that the beneficiary met the clinical criteria at the time GLP-1 therapy was initiated and is participating in a lifestyle modification program

Adults on the drug often need broader support because the drug shifts sleep, gut transit, and heart rate at once

PMID 22836391

Key Points Among 1,021 patients receiving warfarin, TTR decreased by 2.1% following GLP-1 RA initiation